products aor saccharomyces-boulardii

Saccharomyces Boulardii

By : AOR - Advanced Orthomolecular Research

Indications

• Traveller's diarrhea
• Antibiotic-associated diarrhea
• Dysbiosis

Ingredients

Supplement Facts
Serving Size: 1 Capsule

Amount PerServing
Saccharomyces boulardii ATCC74352 …..… 250 mg (5,000,000,000 Organisms)

Non-medicinal ingredients: Capsule: hypromellose.

AOR Guarantees: that no ingredients not listed on the label have been added to the product. Contains no wheat, gluten, corn, nuts, dairy, eggs, fish, shellfish or any animal byproduct.

Source: Biological fermentation

Description

Actions:
• Helps relieve antibiotic-associated diarrhea
• Reduces the symptoms of Traveler's diarrhea
• Helps minimize intestinal complications
• Helps prevent gastrointestinal inflammation

Quantity

90 Vegi-Caps

Dose

Take three capsules per day in divided doses between meals.

Potential side effects/Safety

Cautions: Discontinue use and consult a health care practitioner if symptoms of digestive upset (e.g. diarrhea) occur, worsen, or persist beyond 3 days. Do not use if you are experiencing nausea, fever, vomiting, bloody diarrhea or severe abdominal pain or if you have an immune-compromised condition (e.g. AIDS, lymphoma, patients undergoing long-term corticosteroid treatment). This product has come into contact with soy. Do not use if you have a soy allergy.

Pregnancy/Nursing: Do not use

References

"Show references"

"Hide references"

Bleichner G, Blehaut H, Mentec H, Moyse D. Saccharomyces boulardii prevents diarrhea in critically ill tube-fed patients. A multicenter, randomized, double-blind, placebo-controlled trial. Intensive Care Med. 1997; 23:517-523.

Can M, et al. Prophylactic Saccharomyces boulardii in the prevention of antibiotic-associated diarrhea: a prospective study. Med Sci Monit. 2006 Apr;12(4):PI19-22. Epub 2006 Mar 28.

Castagliuolo I, Riegler MF, Valenick L, et al. Saccharomyces boulardii protease inhibits the effects of Clostridium difficile toxins A and B in human colonic mucosa. Infect Immun. 1999; 67:302-307.

Elmer GW, McFarland LV, Surawicz CM, et al. Behavior of Saccharomyces boulardii in recurrent Clostridium difficile disease patients. Aliment Pharmacol Ther. 1999; 13:1663-1668.

McFarland LV. Meta-analysis of probiotics for the prevention of traveler's diarrhea. Travel Med Infect Dis. 2007 Mar;5(2):97-105. Epub 2005 Dec 5.

Disclaimer: This content is subject to change. The information is intended to inform and educate; it does not replace the medical evaluation, advice, diagnosis or treatment by a healthcare professional. www.healthydigestionclinic.com © 2015 NDAssist Inc. and/or its affiliates. All rights reserved.